Results 11 to 20 of about 35,320 (249)

The promotion of data sharing in pharmacoepidemiology [PDF]

, 2014
This article addresses the role of pharmacoepidemiology in patient safety and the crucial role of data sharing in ensuring that such activities occur. Against the backdrop of proposed reforms of European data protection legislation, it considers whether ...
Sethi, Nayha
core   +1 more source

The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication. [PDF]

, 2016
PurposeTo explore whether privacy restrictions developed to protect patients have complicated research within a 15-year surveillance study conducted with US cancer registries.MethodsData from enrolling 27 cancer registries over a 10-year period were ...
Andrews, Elizabeth B, Deapen, Dennis M, Gilsenan, Alicia W, Harris, David H, Hornicek, Francis J, Midkiff, Kirk D, Schymura, Maria J   +6 more
core   +1 more source

Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce

International Journal of Population Data Science, 2018
Introduction Linked data are increasingly used in pharmacoepidemiology studies to enhance value beyond that which can be achieve from stand-alone pharmaceutical data. The complexity of pharmaceutical data can make any linked data analysis challenging and
Derrick Lopez, Benjamin Daniels, Frank Sanfilippo, Sallie Pearson, Angelita Martini, David B Preen   +5 more
doaj   +1 more source

Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database

Pharmacoepidemiology, 2023
We aimed to evaluate the adverse birth outcomes of anticancer drug prescription during pregnancy using a Japanese claims database from 2005 to 2019.
Kentaro Tajima, Tomofumi Ishikawa, Masami Tsuchiya, Masafumi Kikuchi, Taku Obara, Nariyasu Mano   +5 more
doaj   +1 more source

Literature Review of Safety Event Reporting in Observational Studies: Challenges Extrapolating across Comparable Products

Pharmacoepidemiology, 2023
Nirmatrelvir/ritonavir (PAXLOVIDTM, Pfizer) is an anti-infective inhibiting CYP3A4 indicated for the treatment of COVID-19 in adults at increased risk of severe COVID-19. As a newly approved product, PAXLOVID has limited safety information regarding rare
Heather A. Ward, Bao-Anh Nguyen-Khoa, Robert Massouh   +2 more
doaj   +1 more source

Trends and uptake of new formulations of controlled-release oxycodone in Canada [PDF]

, 2018
Purpose: This study investigated the impact of changing availability of tamper‐deterrent and non‐tamper‐deterrent oxycodone on prescribing patterns of controlled‐release oxycodone across Canada.
Caetano, Patricia, CNODES Investigators, Gomes, Tara, Henry, David, Jain, Sonia, Paterson, J. Michael, Sketris, Ingrid   +6 more
core   +2 more sources

Cost Estimations of Managing Adverse Drug Reactions in Hospitalized Patients: A Systematic Review of Study Methods and Their Influences

Pharmacoepidemiology, 2023
This study aimed to systematically review and explore the impact of study methods on the cost of managing adverse drug reactions (ADRs) among hospitalized patients to guide policymakers and researchers.
Siti Fauziah Abu, Asrul Akmal Shafie, Haarathi Chandriah   +2 more
doaj   +1 more source

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease? [PDF]

, 2017
Pharmacoepidemiology studies are increasingly used for research into safe prescribing in chronic kidney disease (CKD). Typically, patients prescribed a drug are compared with patients who are not on the drug and outcomes are compared to draw conclusions ...
Douglas, Ian, Fogarty, Damian G, Nitsch, Dorothea, Tomlinson, Laurie A   +3 more
core   +1 more source

PHARMACOEPIDEMIOLOGY IN THE ASSORTMENT POLICY-PRODUCER OF DRUGS

Фармация и фармакология (Пятигорск), 2015
RETRACTED ARTICLEThe analysis of the range of the medicines presented by the pharmaceutical company «Servier » in the Russian market, applied is carried out at treatment of a wide range of diseases.
V. Y. Krasnov
doaj   +1 more source

Interactive exploration of population scale pharmacoepidemiology datasets

, 2020
Population-scale drug prescription data linked with adverse drug reaction (ADR) data supports the fitting of models large enough to detect drug use and ADR patterns that are not detectable using traditional methods on smaller datasets. However, detecting
Abadi M., Furu K., Salathé M., Ventola C. L., Wishart D. S.   +4 more
core   +1 more source